STING-STAT6 Signaling Pathway Promotes IL-4+ and IFN-α+ Fibrotic T Cell Activation and Exacerbates Scleroderma in SKG Mice
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Systemic sclerosis (SS) is an autoimmune disease and pathological mechanisms of SS are unclear. In this study, we investigated the role of T cells in the progression of SS using SKG mice and humanized mice. SKG mice have a spontaneous point mutation in ZAP70. We induced scleroderma in SKG mice and a humanized SS mouse model to assess whether T cell-mediated immune responses induce SS. As a result, we found increased dermal thickness, fibrosis, and lymphocyte infiltration in skin tissue in SKG SS mice compared to BALB/c mice (control). Also, blood cytokine level, including IL-4- and IFN-α which are produced by CD4+ T cells via STIM1/STING/STAT6/IRF3 signaling pathways, were increased in SKG mice. Interestingly, skin fibrosis was reduced by inhibiting STING pathway in skin fibroblast. Next, we demonstrated the pathophysiological role of IL-4 and IFN-α in skin fibrosis using a humanized SS mouse model and found increased IL-4- and IFN-α-producing CD4+ T cells and fibrosis. In this study, we found that STING-induced production of IL-4- and type I IFN by CD4+ T cells is a key factor in mouse model and humanized mouse model of SS. Our findings suggest that the STING/STAT6/IRF3 signaling pathways are potential therapeutic targets in SS.
Abstract
Systemic sclerosis (SS) is an autoimmune disease and pathological mechanisms of SS are unclear. In this study, we investigated the role of T cells in the progression of SS using SKG mice and humanized mice. SKG mice have a spontaneous point mutation in ZAP70. We induced scleroderma in SKG mice and a humanized SS mouse model to assess whether T cell-mediated immune responses induce SS. As a result, we found increased dermal thickness, fibrosis, and lymphocyte infiltration in skin tissue in SKG SS mice compared to BALB/c mice (control). Also, blood cytokine level, including IL-4- and IFN-α which are produced by CD4+ T cells via STIM1/STING/STAT6/IRF3 signaling pathways, were increased in SKG mice. Interestingly, skin fibrosis was reduced by inhibiting STING pathway in skin fibroblast. Next, we demonstrated the pathophysiological role of IL-4 and IFN-α in skin fibrosis using a humanized SS mouse model and found increased IL-4- and IFN-α-producing CD4+ T cells and fibrosis. In this study, we found that STING-induced production of IL-4- and type I IFN by CD4+ T cells is a key factor in mouse model and humanized mouse model of SS. Our findings suggest that the STING/STAT6/IRF3 signaling pathways are potential therapeutic targets in SS.
참고문헌 (43)
- Boleto G, "Targeting costimulatory pathways in systemic sclerosis", Front Immunol, 9, pp.2998~ (2018)
- Castello-Cros R, "Scleroderma-like properties of skin from caveolin-1-deficient mice : implications for new treatment strategies in patients with fibrosis and systemic sclerosis", Cell Cycle, 10, pp.2140~2150 (2011)
- Almanzar G, "Memory CD4+ T cells lacking expression of CCR7 promote pro-inflammatory cytokine production in patients with diffuse cutaneous systemic sclerosis", Eur J Dermatol, 29, pp.468~476 (2019)
- Yamamoto T, "Autoimmune mechanisms of scleroderma and a role of oxidative stress", Self Nonself, 2, pp.4~10 (2011)
- Yap HY, "Pathogenic role of immune cells in rheumatoid arthritis : implications in clinical treatment and biomarker development", Cells, 7, pp.161~ (2018)
- Mavalia C, "Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis", Am J Pathol, 151, pp.1751~1758 (1997)
- Radstake TR, "The pronounced Th17 profile in systemic sclerosis(SSc)together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes", PLoS One, 4, pp.e5903~ (2009)
- Xing X, "IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathway", PLoS One, 8, pp.e85032~ (2013)
- Brembilla NC, "Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts : differential effects in healthy and systemic sclerosis fibroblasts", Arthritis Res Ther, 15, pp.R151~ (2013)
- Trebak M, "Calcium signalling in T cells", Nat Rev Immunol, 19, pp.154~169 (2019)
- Woo JS, "Calcium Entry Channels in Non-Excitable Cells", pp.2018, Press
- Srikanth S, "The Ca2+ sensor STIM1 regulates the type I interferon response by retaining the signaling adaptor STING at the endoplasmic reticulum", Nat Immunol, 20, pp.152~162 (2019)
- Son A, "STIM1 holds a STING in its(N-terminal)tail", Cell Calcium, 80, pp.192~193 (2019)
- Tanaka Y, "STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway", Sci Signal, 5, pp.ra20~ (2012)
- Zhang X, "Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING", Mol Cell, 51, pp.226~235 (2013)
- Zhao B, "A conserved PLPLRT", SD motif of STING mediates the recruitment and activation of TBK1, 2019, pp.569, 718~722
- Liu S, "Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation", Science, 347, pp.aaa2630~ (2015)
- Chen H, "Activation of STAT6 by STING is critical for antiviral innate immunity", Cell, 147, pp.436~446 (2011)
- Santana-de Anda K, "Interferon regulatory factor 3 as key element of the interferon signature in plasmacytoid dendritic cells from systemic lupus erythematosus patients : novel genetic associations in the Mexican mestizo population", Clin Exp Immunol, 178, pp.428~437 (2014)
- Takeda K, "Essential role of Stat6 in IL-4 signalling", Nature, 380, pp.627~630 (1996)
- Hsu LY, "A hypomorphic allele of ZAP-70 reveals a distinct thymic threshold for autoimmune disease versus autoimmune reactivity", J Exp Med, 206, pp.2527~2541 (2009)
- Sakaguchi N, "Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice", Nature, 426, pp.454~460 (2003)
- Hata H, "Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice", J Clin Invest, 114, pp.582~588 (2004)
- Park MJ, "Establishment of a humanized animal model of systemic sclerosis in which T helper-17 cells from patients with systemic sclerosis infiltrate and cause fibrosis in the lungs and skin", Exp Mol Med, 54, pp.1577~1585 (2022)
- Derk CT, "Systemic sclerosis : current views of its pathogenesis", Autoimmun Rev, 2, pp.181~191 (2003)
- Denton CP, "Scleroderma--clinical and pathological advances", Best Pract Res Clin Rheumatol, 18, pp.271~290 (2004)
- O’Reilly S, "T cells in systemic sclerosis : a reappraisal", Rheumatology(Oxford), 51, pp.1540~1549 (2012)
- Famularo G, "Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis", Clin Exp Immunol, 81, pp.368~372 (1990)
- Wynn TA, "Fibrotic disease and the T(H)1", T(H)2 paradigm, 2004, pp.4, 583~594
- Salmon-Ehr V, "Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis", Arch Dermatol, 132, pp.802~806 (1996)
- Parel Y, "Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis", Arthritis Rheum, 56, pp.3459~3467 (2007)
- Distler JH, "Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells", Arthritis Rheum, 54, pp.214~225 (2006)
- Ong C, "Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma", Eur J Immunol, 28, pp.2619~2629 (1998)
- Lee KS, "Regulation of interleukin-4 on collagen gene expression by systemic sclerosis fibroblasts in culture", J Dermatol Sci, 12, pp.110~117 (1996)
- Chizzolini C, "Is there a role for IL-17 in the pathogenesis of systemic sclerosis?", Immunol Lett, 195, pp.61~67 (2018)
- Kurasawa K, "Increased interleukin-17 production in patients with systemic sclerosis", Arthritis Rheum, 43, pp.2455~2463 (2000)
- Wilson MS, "Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent", J Exp Med, 207, pp.535~552 (2010)
- Gonçalves RS, "IL-17 and related cytokines involved in systemic sclerosis : Perspectives", Autoimmunity, 51, pp.1~9 (2018)
- Simpson SR, "T cells produce IFN-α in the TREX1 D18N model of lupus-like autoimmunity", J Immunol, 204, pp.348~359 (2020)
- Ding X, "IFN-I mediates lupus nephritis from the beginning to renal fibrosis", Front Immunol, 12, pp.676082~ (2021)
- Skaug B, "Type I interferon dysregulation in Systemic Sclerosis", Cytokine, 132, pp.154635~ (2020)
- Kippenberger S, "STAT6-dependent collagen synthesis in human fibroblasts is induced by bovine milk", PLoS One, 10, pp.e0131783~ (2015)
- Nguyen JK, "The IL-4", IL-13 axis in skin fibrosis and scarring : mechanistic concepts and therapeutic targets, 2020, pp.312, 81~92